Cargando…

Anatomic distribution of supraclavicular lymph node in patients with esophageal cancer

PURPOSE: Definitive chemoradiation therapy remains the standard of care for patients with localized esophageal carcinoma who choose nonsurgical management. However, there is no consensus regarding delineation of the nodal clinical target volume (CTVn), especially for lower cervical lymph nodes. This...

Descripción completa

Detalles Bibliográficos
Autores principales: Xing, Jun, Luo, Yijun, Wang, Xiaoli, Gao, Min, Sun, Mingping, Ding, Xiuping, Fan, Tingyong, Yu, Jinming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5036650/
https://www.ncbi.nlm.nih.gov/pubmed/27703379
http://dx.doi.org/10.2147/OTT.S111800
_version_ 1782455591774453760
author Xing, Jun
Luo, Yijun
Wang, Xiaoli
Gao, Min
Sun, Mingping
Ding, Xiuping
Fan, Tingyong
Yu, Jinming
author_facet Xing, Jun
Luo, Yijun
Wang, Xiaoli
Gao, Min
Sun, Mingping
Ding, Xiuping
Fan, Tingyong
Yu, Jinming
author_sort Xing, Jun
collection PubMed
description PURPOSE: Definitive chemoradiation therapy remains the standard of care for patients with localized esophageal carcinoma who choose nonsurgical management. However, there is no consensus regarding delineation of the nodal clinical target volume (CTVn), especially for lower cervical lymph nodes. This study aimed to map the location of metastatic supraclavicular lymph nodes in thoracic esophageal carcinoma patients with supraclavicular node involvement and generate an atlas to delineate the CTVn for elective nodal radiation of esophageal squamous cell carcinoma. PATIENTS AND METHODS: In this study, the supraclavicular regional lymph node was further divided into four subgroups. The locations of the involved supraclavicular nodes for all patients were then transferred onto a template computed tomography (CT) image. A volume probability map was then generated with nodal volumes, and was displayed on the template CT to provide a visual impression of nodal frequencies and anatomic distribution. RESULTS: We identified 154 supraclavicular nodal metastases based on CT image in 96 patients. Of these, 29.2% were located in group I region, 59.7% in group II region, 10.4% in group III region, and 0.7% in group IV region. CONCLUSION: On the basis of our study, we suggest that the appropriate radiation field of CTVn should include the group I and II regions and the CTVn exterior margin along the lateral side of the internal jugular vein may be suitable.
format Online
Article
Text
id pubmed-5036650
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-50366502016-10-04 Anatomic distribution of supraclavicular lymph node in patients with esophageal cancer Xing, Jun Luo, Yijun Wang, Xiaoli Gao, Min Sun, Mingping Ding, Xiuping Fan, Tingyong Yu, Jinming Onco Targets Ther Original Research PURPOSE: Definitive chemoradiation therapy remains the standard of care for patients with localized esophageal carcinoma who choose nonsurgical management. However, there is no consensus regarding delineation of the nodal clinical target volume (CTVn), especially for lower cervical lymph nodes. This study aimed to map the location of metastatic supraclavicular lymph nodes in thoracic esophageal carcinoma patients with supraclavicular node involvement and generate an atlas to delineate the CTVn for elective nodal radiation of esophageal squamous cell carcinoma. PATIENTS AND METHODS: In this study, the supraclavicular regional lymph node was further divided into four subgroups. The locations of the involved supraclavicular nodes for all patients were then transferred onto a template computed tomography (CT) image. A volume probability map was then generated with nodal volumes, and was displayed on the template CT to provide a visual impression of nodal frequencies and anatomic distribution. RESULTS: We identified 154 supraclavicular nodal metastases based on CT image in 96 patients. Of these, 29.2% were located in group I region, 59.7% in group II region, 10.4% in group III region, and 0.7% in group IV region. CONCLUSION: On the basis of our study, we suggest that the appropriate radiation field of CTVn should include the group I and II regions and the CTVn exterior margin along the lateral side of the internal jugular vein may be suitable. Dove Medical Press 2016-09-22 /pmc/articles/PMC5036650/ /pubmed/27703379 http://dx.doi.org/10.2147/OTT.S111800 Text en © 2016 Xing et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Xing, Jun
Luo, Yijun
Wang, Xiaoli
Gao, Min
Sun, Mingping
Ding, Xiuping
Fan, Tingyong
Yu, Jinming
Anatomic distribution of supraclavicular lymph node in patients with esophageal cancer
title Anatomic distribution of supraclavicular lymph node in patients with esophageal cancer
title_full Anatomic distribution of supraclavicular lymph node in patients with esophageal cancer
title_fullStr Anatomic distribution of supraclavicular lymph node in patients with esophageal cancer
title_full_unstemmed Anatomic distribution of supraclavicular lymph node in patients with esophageal cancer
title_short Anatomic distribution of supraclavicular lymph node in patients with esophageal cancer
title_sort anatomic distribution of supraclavicular lymph node in patients with esophageal cancer
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5036650/
https://www.ncbi.nlm.nih.gov/pubmed/27703379
http://dx.doi.org/10.2147/OTT.S111800
work_keys_str_mv AT xingjun anatomicdistributionofsupraclavicularlymphnodeinpatientswithesophagealcancer
AT luoyijun anatomicdistributionofsupraclavicularlymphnodeinpatientswithesophagealcancer
AT wangxiaoli anatomicdistributionofsupraclavicularlymphnodeinpatientswithesophagealcancer
AT gaomin anatomicdistributionofsupraclavicularlymphnodeinpatientswithesophagealcancer
AT sunmingping anatomicdistributionofsupraclavicularlymphnodeinpatientswithesophagealcancer
AT dingxiuping anatomicdistributionofsupraclavicularlymphnodeinpatientswithesophagealcancer
AT fantingyong anatomicdistributionofsupraclavicularlymphnodeinpatientswithesophagealcancer
AT yujinming anatomicdistributionofsupraclavicularlymphnodeinpatientswithesophagealcancer